Reuven Yeganeh - 13 Jan 2026 Form 3 Insider Report for BiomX Inc. (PHGE)

Signature
/s/ Reuven Yeganeh
Issuer symbol
PHGE
Transactions as of
13 Jan 2026
Net transactions value
$0
Form type
3
Filing time
16 Jan 2026, 19:59:12 UTC
Previous filing
20 Nov 2025
Next filing
13 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yeganeh Reuven Director, 10%+ Owner C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4, NESS ZIONA /s/ Reuven Yeganeh 16 Jan 2026 0002044677

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PHGE Series Y Convertible Preferred Stock 13 Jan 2026 Common Stock 1,650,000 $2.00 By Pyu Pyu Capital, LLC F1, F2
holding PHGE Common Stock Purchase Warrants 13 Jan 2026 Common Stock 3,300,000 $2.00 By Pyu Pyu Capital, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series Y Convertible Preferred Stock is initially convertible into common stock at a conversion price of $2.00 per share, subject to customary anti-dilution adjustments for stock splits, stock dividends, recapitalizations and similar transactions. In addition, upon receipt of the requisite stockholder approval, the conversion price may be adjusted as provided in the Certificate of Designation.
F2 The reported securities are held by Pyu Pyu Capital, LLC, of which the reporting person is the sole member, and over which the reporting person exercises sole voting and dispositive power.